Vaccine

Papers
(The H4-Index of Vaccine is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Editorial Board/Aims and Scope815
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection – a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23)388
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice338
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics216
List of abbreviations and acronyms used in Vaccine Value Profiles193
A non-toxic recombinant bivalent chimeric protein rETXm3CSAm4/TMD as a potential vaccine candidate against enterotoxemia and braxy190
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immun186
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom178
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021167
Editorial Board/Aims and Scope156
Editorial Board/Aims and Scope149
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus c145
Raman spectroscopy as a tool for detection of lung cancer and verification of vaccination effect – Correlation with biochemical data143
Navigating the future of vaccination strategies: Insights from the 17th annual vaccine congress135
Editorial Board129
Editorial Board/Aims and Scope127
Editorial Board/Aims and Scope124
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates120
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial116
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies111
Reverse vaccinology: A strategy also used for identifying potential vaccine antigens in poultry103
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria94
Real-world evidence of yellow Fever vaccination data-driven study93
Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine93
Long-term antibody trajectories after PPSV23 in elderly: Results from a 4-year follow-up study93
Protection against tuberculosis by vaccination of secreted chorismate mutase (Rv1885c) combined with a hepatitis B virus (HBV)-derived peptide, Poly6, and alum adjuvants92
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein92
Meeting summary: Global vaccine and immunization research forum, 202387
Enhanced immunogenicity of a BoHV-1 gG-/tk- vaccine87
Implementation of mid-adult HPV vaccination guidelines into clinical practice86
Modelling the impact and cost-effectiveness of upcoming Zika virus vaccines on congenital Zika syndrome86
Editorial Board/Aims and Scope81
Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule: Response letter, to letter to the edit81
Linking cohort data and Welsh routine health records to investigate children at risk of delayed primary vaccination80
Editorial Board/Aims and Scope80
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses79
Country immunization policies for refugees across 20 low-middle income and 20 high-income countries76
Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018–202375
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019–202275
Assessing the risks of current COVID-19 challenge trials systematically75
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England75
Effectiveness of BNT162b2 XBB.1.5 vaccine in immunocompetent adults using tokenization in two U.S. states74
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera73
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine72
Determinants of seasonal influenza vaccination uptake, intention and recommendations among Lebanese physicians70
Development of a genetically modified full-length human respiratory syncytial virus preF protein vaccine68
Editorial Board68
Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 203066
In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum66
Development of COVID-19 vaccine policy — United States, 2020–202365
Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A natio65
Editorial Board/Aims and Scope65
Parental plans to vaccinate children for COVID-19 in New York city63
Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda62
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs62
Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial62
Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys62
COVID-19 vaccine hesitancy among persons living in homeless shelters in France62
Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis61
Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection61
How can we improve the acceptability of vaccination against Human Papillomavirus (HPV) in France? An original qualitative study with focus groups comprising parents and school staff, interviewed separ61
3.1895821094513